Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of the study is to determine whether the use of the CEST sequence would have diagnostic performance equivalent to the reference method of T2\* infusion with contrast injection in the diagnosis of radionecrosis of lung cancer brain metastases.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients \> 18 years of age
• Histologically proven primary lung cancer
• Histologically proven or not brain metastases
• Irradiated metastases
• Inclusion in a treatment protocol for brain metastases by brain metastasis in toto or stereotactic or gamma-knife radiotherapy
• Morphological increase of one or more lesions of secondary brain metastases on a follow-up MRI
• Patients affiliated to a social security scheme
Locations
Other Locations
France
Hôpital Bichat-Claude Bernard
RECRUITING
Paris
Contact Information
Primary
Augustin Gaudemer, MD
augustin.gaudemer@aphp.fr
01 40 25 76 13
Backup
Marie-Cécile Henry-Feugeas, MD
marie-cecile.henry-feugeas@aphp.fr
01 40 25 81 52
Time Frame
Start Date: 2024-02-15
Estimated Completion Date: 2027-02-15
Participants
Target number of participants: 60
Treatments
Other: Radiation therapy
Patient treated for metastatic cerebral lung cancer who has been treated with external beam radiotherapy such as in toto brain irradiation or stereotactic radiosurgery followed in the thoracic oncology department of Bichat Hospital.
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris